questionsmedicales.fr
Actions chimiques et utilisations
Actions pharmacologiques
Effets physiologiques des médicaments
Hypoglycémiants
Hypoglycémiants : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hypoglycémie
Diabète
Glycémie
Diabète
Glycémie
Test de tolérance au glucose
Hypoglycémie
Symptômes
Palpitations
Hypoglycémie
Consultation médicale
Symptômes
Symptômes
5
Hypoglycémie
Fatigue
Irritabilité
Hypoglycémie
Convulsions
Coma
Hypoglycémie
Sensibilité
Symptômes
Hypoglycémie
Intervention médicale
Symptômes
Prévention
5
Prévention
Hypoglycémie
Alimentation
Exercice
Prévention
Glycémie
Surveillance
Glycémie
Prévention
Éducation
Hypoglycémie
Symptômes
Régime alimentaire
Hypoglycémie
Glycémie
Traitements
5
Hypoglycémiants
Metformine
Sulfonylurées
Hypoglycémie
Glucose
Administration intraveineuse
Hypoglycémiants
Effets secondaires
Nausées
Hypoglycémiants
Ajustement du traitement
Glycémie
Hypoglycémiants
Diabète
Efficacité
Complications
5
Hypoglycémie
Complications
Accidents vasculaires cérébraux
Hypoglycémie
Séquelles
Neurologique
Hypoglycémie
Qualité de vie
Anxiété
Complications
Hypoglycémie
Traitement
Hypoglycémie
Risques à long terme
Cardiovasculaire
Facteurs de risque
5
Hypoglycémie
Facteurs de risque
Diabète
Âge
Hypoglycémie
Sensibilité
Antécédents familiaux
Diabète
Hypoglycémie
Stress
Hypoglycémie
Glycémie
Médicaments
Hypoglycémie
Bêta-bloquants
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypoglycémiants : Questions médicales les plus fréquentes",
"headline": "Hypoglycémiants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypoglycémiants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-16",
"dateModified": "2025-03-11",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypoglycémiants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Effets physiologiques des médicaments",
"url": "https://questionsmedicales.fr/mesh/D045505",
"about": {
"@type": "MedicalCondition",
"name": "Effets physiologiques des médicaments",
"code": {
"@type": "MedicalCode",
"code": "D045505",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs des glycoside hydrolases",
"alternateName": "Glycoside Hydrolase Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D065089",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs des glycoside hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D065089",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes des récepteurs de l'amyline",
"alternateName": "Amylin Receptor Agonists",
"url": "https://questionsmedicales.fr/mesh/D065091",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes des récepteurs de l'amyline",
"code": {
"@type": "MedicalCode",
"code": "D065091",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.374"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs de la dipeptidyl-peptidase IV",
"alternateName": "Dipeptidyl-Peptidase IV Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D054873",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs de la dipeptidyl-peptidase IV",
"code": {
"@type": "MedicalCode",
"code": "D054873",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Secrétagogues à l'insuline",
"alternateName": "Insulin Secretagogues",
"url": "https://questionsmedicales.fr/mesh/D000092005",
"about": {
"@type": "MedicalCondition",
"name": "Secrétagogues à l'insuline",
"code": {
"@type": "MedicalCode",
"code": "D000092005",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agonistes du PPAR gamma",
"alternateName": "PPAR-gamma Agonists",
"url": "https://questionsmedicales.fr/mesh/D000092126",
"about": {
"@type": "MedicalCondition",
"name": "Agonistes du PPAR gamma",
"code": {
"@type": "MedicalCode",
"code": "D000092126",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.688"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Inhibiteurs du cotransporteur sodium-glucose de type 2",
"alternateName": "Sodium-Glucose Transporter 2 Inhibitors",
"url": "https://questionsmedicales.fr/mesh/D000077203",
"about": {
"@type": "MedicalCondition",
"name": "Inhibiteurs du cotransporteur sodium-glucose de type 2",
"code": {
"@type": "MedicalCode",
"code": "D000077203",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.505.696.422.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hypoglycémiants",
"alternateName": "Hypoglycemic Agents",
"code": {
"@type": "MedicalCode",
"code": "D007004",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nunzio Cardullo",
"url": "https://questionsmedicales.fr/author/Nunzio%20Cardullo",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Giuseppe Floresta",
"url": "https://questionsmedicales.fr/author/Giuseppe%20Floresta",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Vera Muccilli",
"url": "https://questionsmedicales.fr/author/Vera%20Muccilli",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Antonio Rescifina",
"url": "https://questionsmedicales.fr/author/Antonio%20Rescifina",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Corrado Tringali",
"url": "https://questionsmedicales.fr/author/Corrado%20Tringali",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[The virtual ILD board: a pilot project].",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37696286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2113-0556"
}
},
{
"@type": "ScholarlyArticle",
"name": "A realist review of dyslexia pilot project research.",
"datePublished": "2023-06-10",
"url": "https://questionsmedicales.fr/article/37300716",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11881-023-00284-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Quality Improvement Pilot Project for Noise Reduction in the NICU.",
"datePublished": "2023-04-05",
"url": "https://questionsmedicales.fr/article/37018178",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ANC.0000000000001074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suicide Attempt Aftercare in Geriatric Patients: A Pilot Project.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36170052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01612840.2022.2127039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Adjunct Techniques in the Assessment of Hypovolemia: A Prospective Pilot Project.",
"datePublished": "2023-09-10",
"url": "https://questionsmedicales.fr/article/37690381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2023.08.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Actions pharmacologiques",
"item": "https://questionsmedicales.fr/mesh/D020228"
},
{
"@type": "ListItem",
"position": 4,
"name": "Effets physiologiques des médicaments",
"item": "https://questionsmedicales.fr/mesh/D045505"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hypoglycémiants",
"item": "https://questionsmedicales.fr/mesh/D007004"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypoglycémiants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypoglycémiants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypoglycémiants",
"description": "Comment diagnostiquer une hypoglycémie ?\nQuels tests sont utilisés pour le diabète ?\nQuels symptômes indiquent une hypoglycémie ?\nQuand consulter un médecin pour hypoglycémie ?\nQuel rôle joue l'HbA1c dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypoglycémiants",
"description": "Quels sont les signes d'une hypoglycémie ?\nComment reconnaître une hypoglycémie sévère ?\nLes symptômes varient-ils selon les personnes ?\nQuels symptômes nécessitent une intervention rapide ?\nLes symptômes peuvent-ils être confondus avec d'autres ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypoglycémiants",
"description": "Comment prévenir l'hypoglycémie ?\nQuel rôle joue l'exercice dans la prévention ?\nLes patients doivent-ils surveiller leur glycémie ?\nComment éduquer les patients sur l'hypoglycémie ?\nLes régimes alimentaires peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypoglycémiants",
"description": "Quels sont les principaux hypoglycémiants ?\nComment administrer du glucose en cas d'hypoglycémie ?\nQuels sont les effets secondaires des hypoglycémiants ?\nComment ajuster le traitement hypoglycémiant ?\nLes hypoglycémiants sont-ils efficaces pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypoglycémiants",
"description": "Quelles sont les complications de l'hypoglycémie ?\nL'hypoglycémie peut-elle entraîner des séquelles ?\nComment l'hypoglycémie affecte-t-elle la qualité de vie ?\nLes complications sont-elles réversibles ?\nQuels sont les risques à long terme de l'hypoglycémie ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypoglycémiants",
"description": "Quels sont les facteurs de risque d'hypoglycémie ?\nL'âge influence-t-il le risque d'hypoglycémie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il aggraver l'hypoglycémie ?\nLes médicaments peuvent-ils influencer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D007004?mesh_terms=Pilot+Projects#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une hypoglycémie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoglycémie est diagnostiquée par des tests de glycémie inférieure à 70 mg/dL."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diabète ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la glycémie à jeun, l'HbA1c et le test de tolérance au glucose."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une hypoglycémie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent tremblements, sueurs, confusion et palpitations."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour hypoglycémie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'HbA1c dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'HbA1c évalue le contrôle glycémique sur 2-3 mois, utile pour le diagnostic du diabète."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une hypoglycémie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fatigue, irritabilité, faim intense et vertiges."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hypoglycémie sévère ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une hypoglycémie sévère peut provoquer des convulsions, une perte de conscience ou un coma."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les personnes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier d'une personne à l'autre en fonction de la sensibilité."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une intervention rapide ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes graves comme confusion, convulsions ou perte de conscience nécessitent une aide immédiate."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être confondus avec ceux d'autres conditions comme l'anxiété ou l'AVC."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypoglycémie ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prévenir l'hypoglycémie nécessite une alimentation équilibrée et un suivi régulier de la glycémie."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'exercice dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier aide à réguler la glycémie et à prévenir les épisodes d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils surveiller leur glycémie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la surveillance régulière de la glycémie est essentielle pour prévenir l'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur l'hypoglycémie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation doit inclure la reconnaissance des symptômes et les mesures à prendre en cas d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les régimes alimentaires peuvent-ils aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un régime alimentaire équilibré et riche en fibres peut aider à stabiliser la glycémie."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux hypoglycémiants ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux hypoglycémiants incluent la metformine, les sulfonylurées et les inhibiteurs DPP-4."
}
},
{
"@type": "Question",
"name": "Comment administrer du glucose en cas d'hypoglycémie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le glucose peut être administré par voie orale ou intraveineuse selon la gravité."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des hypoglycémiants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des diarrhées et des hypoglycémies."
}
},
{
"@type": "Question",
"name": "Comment ajuster le traitement hypoglycémiant ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement doit être ajusté en fonction des niveaux de glycémie et des symptômes."
}
},
{
"@type": "Question",
"name": "Les hypoglycémiants sont-ils efficaces pour tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité peut varier selon le type de diabète et la réponse individuelle."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de l'hypoglycémie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, des accidents vasculaires cérébraux et des chutes."
}
},
{
"@type": "Question",
"name": "L'hypoglycémie peut-elle entraîner des séquelles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des épisodes répétés peuvent causer des dommages neurologiques permanents."
}
},
{
"@type": "Question",
"name": "Comment l'hypoglycémie affecte-t-elle la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypoglycémie fréquente peut entraîner une anxiété accrue et une diminution de la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles si l'hypoglycémie est traitée rapidement."
}
},
{
"@type": "Question",
"name": "Quels sont les risques à long terme de l'hypoglycémie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme incluent des troubles cognitifs et une augmentation du risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'hypoglycémie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent un traitement intensif du diabète, une alimentation irrégulière et l'alcool."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypoglycémie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées sont plus susceptibles de souffrir d'hypoglycémie en raison de la sensibilité accrue."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de diabète peuvent augmenter le risque d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'hypoglycémie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affecter la glycémie et augmenter le risque d'hypoglycémie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils influencer le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments, comme les bêta-bloquants, peuvent masquer les symptômes d'hypoglycémie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 11/03/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, China.
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
College of Food Science and Engineering, Northwest A&F University, Yangling, China.
Publications dans "Hypoglycémiants" :
2 publications dans cette catégorie
Affiliations :
Department of Clinical Pharmacy, King Khalid University, Abha, Saudi Arabia.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and National Engineering Research Center for Functional Food, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China and Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu 214122, P.R. China. shuhuai@jiangnan.edu.cn zhaow@jiangnan.edu.cn.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Aalborg, Denmark.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Department of Anesthesiology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA. Electronic address: angela.selzer@cuanschutz.edu.
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Publications dans "Hypoglycémiants" :
1 publication dans cette catégorie
Affiliations :
Rutgers Robert Wood Johnson Medical School, Piscataway, NJ, USA.
Publications dans "Hypoglycémiants" :
Interstitial lung diseases are associated with high morbitity and mortality. Rapid diagnosis in a qualified center is necessary in order to provide the best possible treatment. However, geographic dis...
We conducted a realist review of state-authorized dyslexia pilot projects to understand how they have been implemented and evaluated, and the extent to which they adhere to best practice recommendatio...
Increased noxious noise leads to adverse short-term and long-term effects on the growing neonate. The American Academy of Pediatrics recommends maintaining a noise level of less than 45 decibels (dBA)...
The purpose of this pilot project was to reduce the average noise levels by 39% at the end of an 11-week period....
The location of the project was in a large, high-acuity level IV open-pod layout NICU that consisted of 4 pods, one of which was cardiac-focused. The average baseline noise level in the cardiac pod wa...
At the end of the project, noise levels decreased from 62.6 dBA to 54 dBA, a 13.7% reduction....
At the end of this pilot project it was noted that: Online modules were the best way to educate staff. Parents should be included in the implementation of quality improvement. Healthcare providers nee...
Hospitalized patients after suicide attempts gave informed consent to a postvention project after discharge. A continuous caregiver contacted the subjects monthly by phone for a period of 1 year. In c...
Measuring the hypovolemic resuscitation end point remains a critical care challenge. Our project compared clinical hypovolemia (CH) with three diagnostic adjuncts: 1) noninvasive cardiac output monito...
Adult trauma/surgical intensive care unit patients were prospectively screened for suspected hypovolemia after acute resuscitation, excluding patients with burns, known heart failure, or severe liver/...
44 patients (62% male, median age 60) yielded 65 measures. Positive agreement with CH was 47% for NICOM, 37% for US-IVC and 10% for US-C. None of the three adjuncts correlated with CH (κ -0.045 to 0.0...
None of the adjunct measurements correlated with CH or each other, highlighting that fluid status assessment remains challenging in critical care. US should assess for right ventricular dysfunction pr...
People living with chronic disease should ideally engage with community-based exercise services following hospital-based rehabilitation. However, transition from hospital to community exercise setting...
The aims of this study were to develop and explore the feasibility of a pilot exercise referral pathway between an acute hospital and community gyms for patients with chronic health conditions and to ...
A stakeholder-informed exercise referral pathway was developed and offered to patients following completion of a hospital-based exercise programme for a chronic health condition. The pathway was evalu...
Forty-nine people living with chronic conditions (mean age 72 ± 7.8 years) participated (recruitment rate 59%). The average number of community gym visits over 4 months was 17.4 (range 0-51). Twenty-n...
A structured exercise referral pathway to support exercise transition between hospital and community settings in populations with chronic health conditions appears feasible. Participants reported high...
This manuscript offers findings from a pilot project which prepares nursing students for embodied professional practice through the lens of ethics. Four undergraduate nursing students were mentored by...
Chlamydia disproportionately affects individuals aged 15-24 years. A lack of chlamydia knowledge in this high-risk group likely contributes to decreased testing, but interventions to increase chlamydi...
A pre- and post-test design was used to evaluate participant knowledge of chlamydia before and after completing a nurse-developed web-based education intervention designed for university students....
Forty-seven undergraduate students at one U.S. university participated. A focus group and scientific evidence informed the development of the web-based education....
Participants had a significant increase in chlamydia knowledge after completing the online educational intervention (M = 8.0, SD = 0.000) compared to baseline (M = 6.5, SD = 1.5), t(33) = -5.821, p < ...
In the twenty-first century, health systems have to cope with the challenges posed by their rapidly changing environment. Among these changes, the emergence of digital health solutions is an opportuni...
This study is based on a survey of the dental care provided by three units (Oral Medicine, Periodontology, Orthodontics) of the Department of Community Dentistry, Semmelweis University, Budapest. Duri...
According to our findings, teledentistry has the potential to shorten the visit with an average of 5-10 min per patient, which adds up to 58-116 work hours in a year. If the pilot was rolled out to al...
The rapid development of digital health technologies coupled with the evolving task distribution between health professionals have a great potential to improve health system performance in pursuit of ...
Obesity is a chronic, multifactorial disease which is linked to a number of adverse endocrinological and metabolic conditions. Currently, bariatric surgery is one of the most effective treatments for ...